Featured Research

from universities, journals, and other organizations

California's leadership in tobacco control resulted in lower lung cancer rate, study finds

Date:
September 29, 2010
Source:
University of California -- San Diego
Summary:
A new study shows that California's 40 year-long tobacco control program has resulted in lung cancer rates that are nearly 25 percent lower than other states.

A study led by researchers at the University of California, San Diego shows that California's 40 year-long tobacco control program has resulted in lung cancer rates that are nearly 25 percent lower than other states.

"The consistency in the trends from cigarette sales and population surveys was reassuring," said John P. Pierce, PhD, Sam M. Walton Professor of Cancer Research in the Department of Family and Preventive Medicine at UCSD School of Medicine and director of the Population Sciences Division at Moores UCSD Cancer Center. "What is really important is that the widening gap in smoking behavior between California and the rest of the nation is replicated in the lung cancer data 16 years later. There is no other behavior that affects a disease like this."

California established the nation's first comprehensive Tobacco Control Program in 1989. Subsequently, the rate at which Californians reduced smoking doubled. Californians now smoke half as many cigarettes as people in the rest of the country (9.3 percent/17.8 percent), and fewer than 10 percent of its population smokes, according to a study published in the journal Cancer Epidemiology, Biomarkers and Prevention. The study credits the state's aggressive tax on cigarettes and its decades-long, comprehensive tobacco control program.

However, the research also suggests that because -- for the first time in more than 20 years -- California has not kept up with the rest of the nation in increasing the price of cigarettes and is being outspent on tobacco control, its lead in lowering cigarette consumption and lung cancer may shrink in the future.

"We expect that the success of the tobacco control program over the last 16 years will translate into a further widening in lung cancer mortality for the short term future," explained Pierce. "But in the longer term, unless California increases its current tobacco control efforts, it will lose this advantage."

The team analyzed major national surveys conducted since 1965 as well as data from taxed cigarette sales to calculate trends in smoking behavior each year since 1960, and then compared these trends with lung cancer mortality data reported by the Centers for Disease Control.

"Because we had data back to 1960, we were able to show that smoking behavior in California was not different than the rest of the nation before the advent of public health action against smoking," said co-author Karen Messer PhD, professor of family and preventive medicine and director of biostatistics at Moores UCSD Cancer Center. "It was California's statewide leadership in tobacco control that was associated with the lower smoking rates in California as compared to the rest of the nation."

"This definitive study demonstrates that lung cancer can be reduced markedly by increasing excise taxes and running a state-of-the-art tobacco control program," said George Lemp, DrPH, acting director of the Tobacco Related Disease Research Program at the University of California who funded the study.

In addition to Pierce, the research team includes Karen S. Messer, PhD, Martha M. White, and Sheila Kealey, MPH, from Moores UCSD Cancer Center, along with David W. Cowling, PhD, from the California Department of Public Health California Tobacco Control Program.

This study was funded through grants from the University of California Tobacco Related Disease Research Program.


Story Source:

The above story is based on materials provided by University of California -- San Diego. Note: Materials may be edited for content and length.


Journal Reference:

  1. John P. Pierce, Karen S. Messer, Martha M. White, Sheila Kealey, David W. Cowling. Forty Years of Faster Decline in Cigarette Smoking in California Explains Current Lower Lung Cancer Rates. Cancer Epidemiology, Biomarkers and Prevention, 2010; DOI: 10.1158/1055-9965.EPI-10-0563

Cite This Page:

University of California -- San Diego. "California's leadership in tobacco control resulted in lower lung cancer rate, study finds." ScienceDaily. ScienceDaily, 29 September 2010. <www.sciencedaily.com/releases/2010/09/100929142131.htm>.
University of California -- San Diego. (2010, September 29). California's leadership in tobacco control resulted in lower lung cancer rate, study finds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/09/100929142131.htm
University of California -- San Diego. "California's leadership in tobacco control resulted in lower lung cancer rate, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/09/100929142131.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins